Cancer Center Featured Story 2

Add to Favorites Subscribe Share
fbshare-Cancer Center Featured Story 2

Showing results

110 of 1399

Article ID: 713266

Cancer Research Institute Champions Cancer Immunotherapy Month™ in June

Cancer Research Institute

The Cancer Research Institute announced today a series of public education and awareness offerings during its seventh annual Cancer Immunotherapy Month™ in June.

21-May-2019 3:00 PM EDT

Article ID: 713261

Texas raises tobacco sales age to 21 to limit youth exposure and protect health

University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center applauds the Texas Legislature today for passing Senate Bill 21, which raises the minimum legal sale age for all tobacco products from 18 to 21.

21-May-2019 1:05 PM EDT

Law and Public Policy

Embargo will expire:
22-May-2019 5:00 PM EDT
Released to reporters:
21-May-2019 1:05 PM EDT


A reporter's PressPass is required to access this story until the embargo expires on 22-May-2019 5:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Article ID: 713226

Stephen Piscotty of the Oakland Athletics wins 54th Annual Hutch Award

Fred Hutchinson Cancer Research Center

Right fielder honored for overcoming personal tragedy, demonstrating a commitment to scientific research and exemplifying the spirit of Fred Hutchinson

21-May-2019 12:00 PM EDT

Article ID: 713249

David Jaffray, Ph.D., Named Chief Technology and Digital Officer

University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today named David Jaffray, Ph.D., as its first-ever chief technology and digital officer. Jaffray will begin his new duties overseeing MD Anderson’s Information Services division and Information Security department in late summer. He also will hold a faculty appointment as professor of Radiation Physics with a joint appointment in Imaging Physics.

21-May-2019 11:05 AM EDT

Article ID: 713044

Dana-Farber researchers present findings in more than 70 research studies at ASCO annual meeting 2019

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute researchers are presenting more than 70 research studies at the 2019 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 31st- June 4th. ASCO is the world’s largest clinical cancer research meeting, attracting more than 30,000 oncology professionals from around the world.

16-May-2019 3:05 PM EDT

Article ID: 712989

Artificial Intelligence Tool Vastly Scales Up Alzheimer's Research

UC Davis Comprehensive Cancer Center

Researchers at UC Davis Health and UC San Francisco have found a way to teach a computer to detect one of the hallmarks of Alzheimer’s disease

16-May-2019 10:05 AM EDT

Article ID: 712900

Researchers Pinpoint Why Lymphoma Patients May Become Resistant to Specific Therapy, Identify Strategy to Overcome It

Moffitt Cancer Center

With more targeted therapies being approved each year for cancer, the development of drug resistance to these agents is a growing concern. It has often been assumed that drug resistance is due to the presence or development of additional genetic alterations; however, it is now clear that resistance mechanisms are more complicated. Researchers from Moffitt Cancer Center and Dana-Farber Cancer Institute have discovered a mechanism of drug resistance to Venetoclax®, also known as ABT-199, a BCL-2 targeting drug commonly used to treat chronic lymphocytic leukemia and acute myeloid leukemia. Their findings, published in the journal Cancer Cell, also suggest a possible co-treatment strategy to overcome this resistance.

15-May-2019 9:50 AM EDT
  • Embargo expired:
    15-May-2019 5:00 AM EDT

Article ID: 712744

Artificial intelligence tool vastly scales up Alzheimer’s research

UC Davis Health

Researchers at UC Davis and UC San Francisco have found a way to teach a computer to precisely detect one of the hallmarks of Alzheimer’s disease in human brain tissue, delivering a proof of concept for a machine-learning approach to distinguishing critical markers of the disease.

10-May-2019 6:05 PM EDT

Article ID: 712819

Patients’ Own Cells Do the Work in Roswell Park Immunotherapy Study Incorporating Adult Stem Cells

Roswell Park Comprehensive Cancer Center

A clinical trial underway at Roswell Park Comprehensive Cancer Center will assess a brand-new immunotherapy approach — reprogramming a patient’s blood stem cells to generate a lasting supply of two types of immune cells — in patients with recurrent cancer of the ovaries, fallopian tubes or peritoneum.

14-May-2019 10:05 AM EDT

Showing results

110 of 1399

Chat now!